Ian G. Mills

29.8k total citations · 2 hit papers
190 papers, 10.4k citations indexed

About

Ian G. Mills is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ian G. Mills has authored 190 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Molecular Biology, 70 papers in Pulmonary and Respiratory Medicine and 35 papers in Cancer Research. Recurrent topics in Ian G. Mills's work include Prostate Cancer Treatment and Research (66 papers), Cellular transport and secretion (23 papers) and Ubiquitin and proteasome pathways (20 papers). Ian G. Mills is often cited by papers focused on Prostate Cancer Treatment and Research (66 papers), Cellular transport and secretion (23 papers) and Ubiquitin and proteasome pathways (20 papers). Ian G. Mills collaborates with scholars based in United Kingdom, Norway and United States. Ian G. Mills's co-authors include Harvey T. McMahon, Yvonne Vallis, Philip R. Evans, Brian J. Peter, David E. Neal, P.J.G. Butler, Helen M. Kent, Gerrit J. K. Praefcke, Charles Massie and Marijn G. J. Ford and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Ian G. Mills

183 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BAR Domains as Sensors of Membrane Curvature: The Amphiphysin BAR Structure

2003 1.4k citations Brian J. Peter, Helen M. Kent et al. Science profile →
Curvature of clathrin-coated pits driven by epsin

2002 792 citations Ian G. Mills, Brian J. Peter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian G. Mills United Kingdom	52	7.1k	3.5k	1.9k	1.6k	1.2k	190	10.4k
Daniela Rotin Canada	61	10.0k 1.4×	2.1k 0.6×	1.1k 0.6×	909 0.6×	1.8k 1.5×	125	13.0k
Erica A. Golemis United States	63	8.8k 1.2×	3.1k 0.9×	930 0.5×	1.3k 0.8×	2.6k 2.1×	234	12.5k
David A. Lomas United Kingdom	44	4.3k 0.6×	2.0k 0.6×	991 0.5×	3.6k 2.2×	1.6k 1.3×	135	8.8k
Volker Gerke Germany	66	13.6k 1.9×	2.9k 0.8×	1.7k 0.9×	2.8k 1.7×	866 0.7×	255	17.2k
Masato Kato Japan	46	7.5k 1.1×	2.3k 0.7×	571 0.3×	831 0.5×	792 0.6×	187	10.7k
Alex von Kriegsheim United Kingdom	38	5.8k 0.8×	1.4k 0.4×	631 0.3×	4.0k 2.4×	1.3k 1.0×	120	9.2k
Jeroen Demmers Netherlands	58	8.8k 1.2×	2.4k 0.7×	405 0.2×	919 0.6×	951 0.8×	203	13.3k
Linda Rodgers United States	32	8.4k 1.2×	1.3k 0.4×	933 0.5×	2.8k 1.7×	2.1k 1.7×	61	11.4k
Xuebiao Yao China	57	8.5k 1.2×	3.5k 1.0×	428 0.2×	762 0.5×	1.7k 1.4×	260	11.6k
Jan E. Schnitzer United States	47	6.5k 0.9×	4.5k 1.3×	774 0.4×	679 0.4×	748 0.6×	102	10.6k

Countries citing papers authored by Ian G. Mills

Since Specialization

Citations

This map shows the geographic impact of Ian G. Mills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian G. Mills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian G. Mills more than expected).

Fields of papers citing papers by Ian G. Mills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian G. Mills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian G. Mills. The network helps show where Ian G. Mills may publish in the future.

Co-authorship network of co-authors of Ian G. Mills

This figure shows the co-authorship network connecting the top 25 collaborators of Ian G. Mills. A scholar is included among the top collaborators of Ian G. Mills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian G. Mills. Ian G. Mills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poulose, Ninu, et al.. (2024). CDK9 inhibition activates innate immune response through viral mimicry. The FASEB Journal. 38(8). e23628–e23628. 5 indexed citations

O’Reilly, Dawn, Yiannis Philippou, Srinivasa R. Rao, et al.. (2024). Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post‐radiotherapy, and those with de novo metastatic disease. The Prostate. 84(10). 977–990. 1 indexed citations

Williams, Charles H., Leif R. Neitzel, Ian G. Mills, et al.. (2024). GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment. Experimental Hematology and Oncology. 13(1). 13–13. 17 indexed citations

Mohd-Sarip, Adone, et al.. (2023). CACNA1D overexpression and voltage-gated calcium channels in prostate cancer during androgen deprivation. Scientific Reports. 13(1). 4683–4683. 7 indexed citations

Watts, Eleanor L., Aurora Perez‐Cornago, Elizabeth A. Platz, et al.. (2022). The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study. PLoS Medicine. 19(1). e1003859–e1003859. 29 indexed citations

Itkonen, Harri M., Massimo Loda, & Ian G. Mills. (2021). O-GlcNAc Transferase – An Auxiliary Factor or a Full-blown Oncogene?. Molecular Cancer Research. 19(4). 555–564. 27 indexed citations

Magnussen, Anette & Ian G. Mills. (2021). Vascular normalisation as the stepping stone into tumour microenvironment transformation. British Journal of Cancer. 125(3). 324–336. 89 indexed citations

Gillis, Joanna L., Natalie K. Ryan, Swati Irani, et al.. (2021). A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth. eLife. 10. 26 indexed citations

Itkonen, Harri M., Ninu Poulose, Rebecca E. Steele, et al.. (2020). Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9. Molecular Cancer Research. 18(10). 1512–1521. 41 indexed citations

10.

Mukherjee, Debayan, Rebecca E. Steele, Adam Pickard, et al.. (2020). Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer. Cancers. 12(10). 2804–2804. 8 indexed citations

11.

Progida, Cinzia, Stefan J. Barfeld, Bernd Thiede, et al.. (2020). Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells. Communications Biology. 3(1). 123–123. 6 indexed citations

12.

Ramberg, Håkon, Helene Hartvedt Grytli, Alfonso Urbanucci, et al.. (2019). The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells. Molecular Cancer Research. 17(11). 2154–2168. 18 indexed citations

13.

Refaat, Alaa, Hajrah Khawaja, Wendy L. Allen, et al.. (2018). The Unfolded Protein Response: A Novel Therapeutic Target for Poor Prognostic BRAF Mutant Colorectal Cancer. Molecular Cancer Therapeutics. 17(6). 1280–1290. 19 indexed citations

14.

Gerner, Lisa, Koen Temmerman, Hüseyin Besir, et al.. (2016). Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2. Biochemical and Biophysical Research Communications. 476(2). 102–107. 3 indexed citations

15.

Zecchini, Vincent, Basetti Madhu, Roslin Russell, et al.. (2014). Nuclear ARRB 1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. The EMBO Journal. 33(12). 1365–1382. 51 indexed citations

16.

Bon, Hélène, Karan Wadhwa, A. Schreiner, et al.. (2014). Salt-Inducible Kinase 2 Regulates Mitotic Progression and Transcription in Prostate Cancer. Molecular Cancer Research. 13(4). 620–635. 47 indexed citations

17.

Itkonen, Harri M., Sarah Minner, Ingrid Jenny Guldvik, et al.. (2013). O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells. Cancer Research. 73(16). 5277–5287. 243 indexed citations

18.

Warren, Anne Y., Ian G. Mills, Kanagasabai Sahadevan, et al.. (2009). LYRIC/AEG-1 Is Targeted to Different Subcellular Compartments by Ubiquitinylation and Intrinsic Nuclear Localization Signals. Clinical Cancer Research. 15(9). 3003–3013. 74 indexed citations

19.

Wolf, Michael, Henrik Edgren, Ian G. Mills, et al.. (2006). Integrated DNA/RNA microarray profiling of hormone-refractory clinical prostate cancers and metastases indicates deregulation of several pathways, including androgen/AR, Hedgehog, MAPK and neuroactive ligand/receptor signalling. Cancer Research. 66. 1 indexed citations

20.

Peter, Brian J., Helen M. Kent, Ian G. Mills, et al.. (2003). BAR Domains as Sensors of Membrane Curvature: The Amphiphysin BAR Structure. Science. 303(5657). 495–499. 1372 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact